Perihilar cholangiocarcinoma: Current therapy.

Area of Science:

• Oncology
• Gastroenterology
• Surgical Oncology

Background:

• Perihilar cholangiocarcinoma is a rare bile duct cancer.
• It is often diagnosed at advanced stages with a poor prognosis.
• Current primary treatment involves complete hepatectomy.

Purpose of the Study:

• To review and discuss treatment approaches for perihilar cholangiocarcinoma.
• To analyze resectability, mortality, morbidity, and outcomes.
• To evaluate the role of palliative treatments and liver transplantation.

Main Methods:

• Review of multi-institutional data.
• Discussion of surgical and non-surgical treatment strategies.
• Analysis of outcomes based on different therapeutic approaches.

Main Results:

• Complete hepatectomy is the primary curative therapy.
• Negative margin resection is linked to better survival and quality of life.
• Palliative treatments and liver transplantation offer potential benefits but require further validation.

Conclusions:

• Surgical resection is key for perihilar cholangiocarcinoma survival.
• Liver transplantation is a promising option for select patients.
• Further multi-institutional studies are needed to confirm the efficacy of palliative and transplant strategies.